Journal
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION
Volume 11, Issue 1, Pages 37-42Publisher
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/00041552-200201000-00006
Keywords
-
Categories
Funding
- PHS HHS [KO8, R01] Funding Source: Medline
Ask authors/readers for more resources
Renal cell carcinomas account for 80-85% of all primary renal neoplasms. Recent identification of VHL, c-met and TSC as candidate genes mutated in various types of renal carcinomas has greatly enhanced our understanding of the pathogenesis of renal carcinomas and has provided novel therapeutic options for patients with renal cancer. Furthermore, developments in angiogenesis and in tumor immunology have given us additional treatment modalities for cancer patients, especially those with renal cancer. This review highlights the genetic abnormalities seen in renal cell carcinomas and reviews current and future therapeutic options. Curr Opin Nephrol Hypertens 11:37-42. (C) 2002 Lippincott Williams & Wilkins.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available